Diagnosis
DSM-5 diagnosis
The current DSM-5 criteria for Intermittent Explosive Disorder include:
Recurrent outbursts that demonstrate an inability to control impulses, including either of the following:
Verbal aggression (tantrums, verbal arguments, or fights) or physical aggression that occurs twice in a week-long period for at least three months and does not lead to the destruction of property or physical injury (Criterion A1)
Three outbursts that involve injury or destruction within a year-long period (Criterion A2)
Aggressive behavior is grossly disproportionate to the magnitude of the psychosocial stressors (Criterion B)
The outbursts are not premeditated and serve no premeditated purpose (Criterion C)
The outbursts cause distress or impairment of functioning or lead to financial or legal consequences (Criterion D)
The individual must be at least six years old (Criterion E)
The recurrent outbursts cannot be explained by another mental disorder and are not the result of another medical disorder or substance use (Criterion F)It is important to note that DSM-5 now includes two separate criteria for types of aggressive outbursts (A1 and A2) which have empirical support:
Criterion A1: Episodes of verbal and/or non-damaging, nondestructive, or non-injurious physical assault that occur, on average, twice weekly for three months. These could include temper tantrums, tirades, verbal arguments/fights, or assault without damage. This criterion includes high frequency/low-intensity outbursts. Criterion A2: More severe destructive/assaultive episodes which are more infrequent and occur, on average, three times within a twelve-month period. These could be destroying an object without regard to value, assaulting an animal or individual. This criterion includes high-intensity/low-frequency outbursts.
The product was produced as an alternative for people averse to the chalky consistency of regular Rolaids. They were widely advertised in multiple media formats. Rolaids Softchews were originally developed and test marketed in Oklahoma City under the brand name Remegel by Warner Lambert in 1984. Medical information
The active ingredients are calcium carbonate (550 mg) and magnesium hydroxide (110 mg). The inactive ingredients are dextrose, flavoring, magnesium stearate, polyethylene glycol, pregelatinized starch, sucralose and sucrose. The new Chattem varieties have increased the amount of the active ingredients in the product, up to 1000 mg of calcium carbonate and 200 mg of magnesium hydroxide for the "ultra strength" varieties. Minor side effects may include constipation or stomach cramps. Serious side effects include loss of appetite, vomiting, dizziness, and headache. References
External links
Official website